Viewing Study NCT01326156



Ignite Creation Date: 2024-05-05 @ 11:26 PM
Last Modification Date: 2024-10-26 @ 10:33 AM
Study NCT ID: NCT01326156
Status: UNKNOWN
Last Update Posted: 2020-11-06
First Post: 2009-05-19

Brief Title: Study of Knee Replacements for Patellofemoral Osteoarthritis
Sponsor: University of Aarhus
Organization: University of Aarhus

Study Overview

Official Title: Patellofemoral Arthroplasty PFA Versus Total Knee Replacement TKR for Isolated Patellofemoral Osteoarthritis
Status: UNKNOWN
Status Verified Date: 2020-11
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PFATKR
Brief Summary: This is a randomized comparison of PFA and TKR in treatment of isolated patellofemoral osteoarthritis
Detailed Description: Isolated patellofemoral osteoarthritis can be a disabling condition of the knee necessitating knee arthroplasty It is debated whether total knee replacement or isolated patellofemoral replacement is the better treatment option This randomized trial attempts to give a qualified answer to the debate by comparing clinical outcome range of movement stability effusion patellofemoral tracking tenderness stair climbing patient self assessment scores EQ-5D Oxford Knee Score KOOS SF-36 AKS complications infections revisions longevity survival analysis and cost direct and indirect for the two implant types

The Avon patellofemoral implant has been chosen as this is the patellofemoral implant with the best documentation The PFC Sigma CR total knee implant has been chosen as it a current standard implant and market leader

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None